1st Quarter - Report

TIBER CREEK for CIGNA CORPORATION

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 748/S. 684, Middle Class Health Benefits Tax Repeal Act of 2019, legislation to repeal a 40% ACA excise tax on certain employer-sponsored health insurance plans. S.172/H.R. 1398, the Health Insurance Tax (HIT) Relief Act of 2019, legislation to suspend the ACA's health insurance tax (HIT) in 2020 and 2021. S.80, Jobs and Premium Protection Act, full repeal of the HIT.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JAY HEIMBACH —
ANDREW MCKECHNIE —
JEFF SHAPIRO —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), H.R. 1398 (116th), S. 80 (116th), S. 684 (116th), S. 172 (116th)

Health Issues HCR

Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, and non-discrimination provisions. Issues related to H.R. 861, the End Surprise Billing Act.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JAY HEIMBACH —
ANDREW MCKECHNIE —
JEFF SHAPIRO —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 861 (116th)

Medicare/Medicaid MMM

Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. CMS-4182-P/CMS-4182-CN: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2019. Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2020 (CMS-4185-P).

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JAY HEIMBACH —
ANDREW MCKECHNIE —
JEFF SHAPIRO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.